Kazia Therapeutics Limited
KZIA
$3.30
-$0.2395-6.77%
NASDAQ
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.11M | 1.08M | 2.43M | 2.30M | 3.49M |
Total Receivables | 88.70K | 86.70K | 44.60K | 42.20K | 69.90K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 394.30K | 385.40K | 479.40K | 453.90K | 1.09M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 2.51M | 2.45M | 2.51M | 2.37M | 2.53M |
Total Current Assets | 4.10M | 4.01M | 5.46M | 5.17M | 7.17M |
|
|||||
Total Current Assets | 4.10M | 4.01M | 5.46M | 5.17M | 7.17M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 10.27M | 10.04M | 11.13M | 10.54M | 11.49M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 26.70K | 26.10K | 27.30K | 25.80K | 28.60K |
Total Assets | 14.40M | 14.08M | 16.62M | 15.73M | 18.69M |
|
|||||
Total Accounts Payable | 3.03M | 2.97M | 707.70K | 669.90K | 570.40K |
Total Accrued Expenses | 7.26M | 7.10M | 3.60M | 3.41M | 2.77M |
Short-term Debt | 423.00K | 413.40K | 244.90K | 231.90K | 1.20M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 6.49M | 6.35M | 3.17M | 3.00M | 499.20K |
Total Other Current Liabilities | 6.49M | 6.35M | 3.17M | 3.00M | 499.20K |
Total Current Liabilities | 17.21M | 16.82M | 7.73M | 7.32M | 5.03M |
|
|||||
Total Current Liabilities | 17.21M | 16.82M | 7.73M | 7.32M | 5.03M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 423.00K | 413.40K | 244.90K | 231.90K | 1.20M |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 3.87M | 3.79M | 5.30M | 5.02M | 5.64M |
Total Liabilities | 21.08M | 20.61M | 13.03M | 12.34M | 10.67M |
|
|||||
Common Stock & APIC | 67.81M | 66.28M | 67.33M | 63.74M | 64.86M |
Retained Earnings | -76.81M | -75.08M | -66.74M | -63.18M | -59.29M |
Treasury Stock & Other | 2.32M | 2.27M | 3.00M | 2.84M | 2.45M |
Total Common Equity | -6.68M | -6.53M | 3.59M | 3.40M | 8.02M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -6.68M | -6.53M | 3.59M | 3.40M | 8.02M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -6.68M | -6.53M | 3.59M | 3.40M | 8.02M |
|